ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 56 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $70,000 | -68.6% | 124,400 | -43.0% | 0.00% | – |
| Q3 2021 | $223,000 | -19.5% | 218,100 | +8.4% | 0.00% | – |
| Q2 2021 | $277,000 | -65.3% | 201,263 | -57.2% | 0.00% | – |
| Q1 2021 | $799,000 | +0.9% | 469,740 | -26.6% | 0.00% | – |
| Q4 2020 | $792,000 | +232.8% | 639,572 | +281.2% | 0.00% | – |
| Q3 2020 | $238,000 | +105.2% | 167,799 | +74.4% | 0.00% | – |
| Q2 2020 | $116,000 | -5.7% | 96,193 | -7.7% | 0.00% | – |
| Q1 2020 | $123,000 | -89.5% | 104,269 | -81.2% | 0.00% | – |
| Q4 2019 | $1,173,000 | -23.8% | 555,709 | -20.6% | 0.00% | – |
| Q3 2019 | $1,539,000 | -69.7% | 699,676 | -65.1% | 0.00% | – |
| Q2 2019 | $5,077,000 | +29.5% | 2,005,924 | +78.1% | 0.00% | -100.0% |
| Q1 2019 | $3,920,000 | +79.5% | 1,126,303 | +19.1% | 0.00% | – |
| Q4 2018 | $2,184,000 | +15.6% | 945,527 | +92.6% | 0.00% | – |
| Q3 2018 | $1,890,000 | +90.7% | 490,826 | +67.1% | 0.00% | – |
| Q2 2018 | $991,000 | +89.8% | 293,774 | +18.1% | 0.00% | – |
| Q1 2018 | $522,000 | -28.2% | 248,844 | -30.7% | 0.00% | – |
| Q4 2017 | $727,000 | -72.7% | 358,837 | -38.1% | 0.00% | – |
| Q3 2017 | $2,665,000 | +208.4% | 579,388 | +44.1% | 0.00% | – |
| Q2 2017 | $864,000 | +188.0% | 402,089 | +322.3% | 0.00% | – |
| Q1 2017 | $300,000 | -12.8% | 95,205 | -28.0% | 0.00% | – |
| Q4 2016 | $344,000 | +5.2% | 132,284 | +57.5% | 0.00% | – |
| Q3 2016 | $327,000 | +108.3% | 84,000 | +44.1% | 0.00% | – |
| Q2 2016 | $157,000 | -79.2% | 58,300 | -76.2% | 0.00% | – |
| Q1 2016 | $754,000 | +43.3% | 245,053 | +79.6% | 0.00% | – |
| Q4 2015 | $526,000 | -49.2% | 136,414 | -59.8% | 0.00% | – |
| Q3 2015 | $1,036,000 | -44.9% | 339,623 | -23.4% | 0.00% | – |
| Q2 2015 | $1,881,000 | +158.4% | 443,469 | +135.0% | 0.00% | – |
| Q1 2015 | $728,000 | -42.0% | 188,681 | +1.1% | 0.00% | – |
| Q4 2014 | $1,256,000 | +6.3% | 186,604 | -13.3% | 0.00% | – |
| Q3 2014 | $1,182,000 | -73.8% | 215,165 | -51.1% | 0.00% | -100.0% |
| Q2 2014 | $4,506,000 | +99.6% | 439,600 | +133.9% | 0.00% | +100.0% |
| Q1 2014 | $2,257,000 | -23.0% | 187,939 | -27.5% | 0.00% | -50.0% |
| Q4 2013 | $2,933,000 | +106.4% | 259,317 | +96.6% | 0.00% | – |
| Q3 2013 | $1,421,000 | +346.9% | 131,911 | +284.4% | 0.00% | – |
| Q2 2013 | $318,000 | – | 34,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,408,728 | $21,040,000 | 1.36% |
| Palo Alto Investors LP | 1,634,608 | $6,359,000 | 0.37% |
| WealthTrust Axiom LLC | 200,000 | $778,000 | 0.29% |
| Granahan Investment Management | 1,455,676 | $5,663,000 | 0.18% |
| SHEPHERD KAPLAN KROCHUK, LLC | 127,846 | $497,000 | 0.10% |
| Joel Isaacson & Co., LLC | 80,660 | $314,000 | 0.06% |
| Cornerstone Capital, Inc. | 39,700 | $154,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 281,650 | $1,096,000 | 0.02% |
| Advisor Group, Inc. | 131,992 | $513,000 | 0.01% |
| INTEGRATED WEALTH COUNSEL, LLC | 1,000 | $4,000 | 0.01% |